Inventor · disambiguated record
Keith L. Spencer
Also filed as: SPENCER KEITH L · SPENCER KEITH LEE
23 granted patents·18 pending applications·304 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0295US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0395US6927293B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Aug 9, 2005·69 cites·2 claims
- 0494US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0591US9676730B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 13, 2017·9 cites·15 claims
- 0690US9790190B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 17, 2017·7 cites·23 claims
- 0790US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 0890US9309204B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 12, 2016·7 cites·16 claims
- 0989US9416110B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 16, 2016·10 cites·4 claims
- 1089US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 1188US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 1287US8329701B2Dihydrofuro pyrimidines as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Dec 11, 2012·12 cites·27 claims
- 1382US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 1481US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 1577US8853216B2Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitorBENCSIK JOSEF·Filed 2009·Granted Oct 7, 2014·3 cites·5 claims
- 1677US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1777US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1876US7622592B2Carbonylamino-benzimidazole derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Nov 24, 2009·10 cites·18 claims
- 1975US8846683B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Sep 30, 2014·1 cites·35 claims
- 2074US7101884B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Sep 5, 2006·6 cites·12 claims
- 2173US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 2271US9303040B2Substituted piperazines as AKT inhibitorsMITCHELL IAN S·Filed 2007·Granted Apr 5, 2016·1 cites·32 claims
- 2371US8835434B2Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsBENCSIK JOSEF R·Filed 2009·Granted Sep 16, 2014·2 cites·2 claims
- 2471US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2564US2014315887A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 2664US2018169099A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2760US2016235754A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 2858US2014349996A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 2958US2018258054A1Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3056US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3155US2015197496A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 3255US2005130954A1AKT protein kinase inhibitorsFiled 2004·Application pending·0 cites
- 3354US2015191479A1Dihydrofuro pyrimidines as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3450US2013065908A1Dihydrofuro pyrimidines as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3549US2018282324A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2017·Application pending·0 cites
- 3648US2015051217A1Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitorARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3748US2016152574A9Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3844US10329288B2Process for preparing a compoundGENENTECH INC·Filed 2014·Granted Jun 25, 2019·0 cites·20 claims
- 3944US2016251350A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2016·Application pending·0 cites
- 4043US2009149467A1Tyrosine Kinase InhibitorsMERCK & CO INC·Filed 2006·Application pending·0 cites
- 4141US7186723B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Mar 6, 2007·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Keith L. Spencer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →